Stock HASH SIMPLY SOLVENTLESS CONCENTRATES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Simply Solventless Concentrates Ltd.

Equities

HASH

CA82888A1021

Pharmaceuticals

End-of-day quote Toronto S.E.
Other stock markets
 18:00:00 2024-06-13 EDT 		5-day change 1st Jan Change
0.24 CAD -4.00% Intraday chart for Simply Solventless Concentrates Ltd. -12.73% +60.00%
05-27 Simply Solventless Concentrates Ltd. Provides Earnings Guidance for the Second Quarter 2024 CI
05-27 Simply Solventless Outlines Q2 Earnings Guidance; Shares Jump Nearly 29% MT

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 0.975 0.975 7.271
Enterprise Value (EV) 1 0.8948 7.938 8.9
P/E ratio -3.4 x -5.4 x 7.5 x
Yield - - -
Capitalization / Revenue 0.8 x 0.35 x 1.17 x
EV / Revenue 0.74 x 2.84 x 1.44 x
EV / EBITDA -0.4 x -7.09 x 3.81 x
EV / FCF - -7,151,650 x -4,365,513 x
FCF Yield - -0% -0%
Price to Book 4.44 x 21.1 x 1.66 x
Nbr of stocks (in thousands) 3,750 3,750 48,475
Reference price 2 0.2600 0.2600 0.1500
Announcement Date 23-11-03 23-11-03 24-04-29
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales 1 1.216 2.799 6.192
EBITDA 1 -2.255 -1.119 2.339
EBIT 1 -2.323 -1.369 2.015
Operating Margin -191.03% -48.92% 32.55%
Earnings before Tax (EBT) 1 -2.327 -1.684 1.04
Net income 1 -2.327 -1.684 1.04
Net margin -191.28% -60.15% 16.8%
EPS 2 -0.0765 -0.0481 0.0200
Free Cash Flow - -1.11 -2.039
FCF margin - -39.65% -32.93%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 23-11-03 23-11-03 24-04-29
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - 6.96 1.63
Net Cash position 1 0.08 - -
Leverage (Debt/EBITDA) - -6.221 x 0.6964 x
Free Cash Flow - -1.11 -2.04
ROE (net income / shareholders' equity) - -152% 43.3%
ROA (Net income/ Total Assets) - -12% 12%
Assets 1 - 14.02 8.658
Book Value Per Share 2 0.0600 0.0100 0.0900
Cash Flow per Share 2 0.0100 0.0100 0
Capex 1 0.56 0.56 0.06
Capex / Sales 46.24% 19.84% 0.96%
Announcement Date 23-11-03 23-11-03 24-04-29
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
SIMPLY SOLVENTLESS CONCENTRATES LTD. Stock Simply Solventless Concentrates Ltd.
+60.00% 9.39M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+32.48% 5.8B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-26.22% 3.92B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+4.73% 3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-20.86% 2.77B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-11.88% 2.26B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+46.64% 1.95B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-16.71% 1.52B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD Stock Zhejiang Jolly Pharmaceutical Co.,LTD
+44.65% 1.49B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-9.60% 1.49B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. HASH Stock
  4. Financials Simply Solventless Concentrates Ltd.